Clinical trial
Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
NCT01655316 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2011
- Enrollment
- 90 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal supraventricular tachycardia